Published

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychedelics
Date: 2026-12-01
Source: Crossref
DOI: 10.1016/j.psyche.2026.100032
PubMed: Unavailable

Authors

Albertyn Christopher P.Richard Jérémie Shore Ron Carlson Linda E.

Watch author

Derived topics and classifications

psilocybin Cancer Patients Other

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1080/17512433.2025.2515866 10.1002/cncr.35010 10.1002/cncr.35889 10.1016/j.eclinm.2020.100538 10.1016/j.cpr.2024.102505 10.1038/s41598-022-10361-2 10.1002/pon.1556 10.1089/psymed.2023.0007 10.1124/pr.118.017160 10.1146/annurev-psych-032620-031757 10.3390/curroncol33010007 10.1007/s12671-023-02206-4

Indexed papers citing this DOI

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model2026-12-01

Related papers

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18 The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)ClinicalTrials.gov · 2025-07-23 Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03 The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08 Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyClinicalTrials.gov · 2026-02-17 Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsClinicalTrials.gov · 2021-01-07 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-07-31